Related Experiment Video
Updated: Apr 6, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
PI3K signaling in arterial diseases: Non redundant functions of the PI3K isoforms
Adrien Lupieri1, Natalia Smirnova1, Nicole Malet1
1INSERM, U1048, I2MC and Université Toulouse III, Toulouse, F-31300, France.
Insights
Phosphoinositide 3-kinase (PI3K) isoforms play key roles in cardiovascular diseases like atherosclerosis. Understanding PI3K functions in immune and arterial cells is crucial for developing targeted therapies against these common arterial pathologies.
Area of Science:
- Cardiovascular biology and immunology
- Molecular and cellular mechanisms of arterial disease
Background:
- Cardiovascular diseases, including atherosclerosis, restenosis, and thrombotic complications, are leading global causes of mortality.
- Arterial pathologies arise from complex interactions between immune and arterial cells, driving inflammatory and fibroproliferative responses.
- Phosphoinositide 3-kinase (PI3K) signaling is increasingly recognized for its role in these cellular processes.
Purpose of the Study:
- To review the diverse functions of phosphoinositide 3-kinase (PI3K) isoforms in cardiovascular disease.
- To elucidate the specific roles of different PI3K isoforms in immune and arterial cells within the context of arterial pathologies.
- To identify potential PI3K isoform targets for future therapeutic strategies in treating and preventing arterial diseases.
Main Methods:
- Literature review focusing on PI3K isoform functions in cardiovascular and arterial cells.
- Analysis of PI3K isoform expression, activation, and subcellular localization.
- Synthesis of current understanding regarding PI3K's protective or detrimental effects in arterial disease models.
Main Results:
- PI3K family comprises 8 members across classes I, II, and III, with distinct substrate specificities.
- PI3K isoforms exhibit non-redundant functions due to differential expression, activation, and localization.
- Specific PI3K isoforms are implicated in both protective and deleterious effects within immune and arterial cells.
Conclusions:
- Targeting specific PI3K isoforms holds promise for novel therapeutic interventions in cardiovascular diseases.
- Further research is needed to precisely delineate the roles of each PI3K isoform in arterial disease pathogenesis.
- Selective inhibition or activation of PI3K isoforms may offer a strategy to manage atherosclerosis and its complications.
Abstract:
Cardiovascular diseases are the most common cause of death around the world. This includes atherosclerosis and the adverse effects of its treatment, such as restenosis and thrombotic complications. The development of these arterial pathologies requires a series of highly-intertwined interactions between immune and arterial cells, leading to specific inflammatory and fibroproliferative cellular responses. In the last few years, the study of phosphoinositide 3-kinase (PI3K) functions has become an attractive area of investigation in the field of arterial diseases, especially since inhibitors of specific PI3K isoforms have been developed. The PI3K family includes 8 members divided into classes I, II or III depending on their substrate specificity. Although some of the different isoforms are responsible for the production of the same 3-phosphoinositides, they each have specific, non-redundant functions as a result of differences in expression levels in different cell types, activation mechanisms and specific subcellular locations. This review will focus on the functions of the different PI3K isoforms that are suspected as having protective or deleterious effects in both the various immune cells and types of cell found in the arterial wall. It will also discuss our current understanding in the context of which PI3K isoform(s) should be targeted for future therapeutic interventions to prevent or treat arterial diseases.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
IP3/DAG Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...

